Corporate action official notices

Admission

Put Warrant on MP Materials

CH1579878476

Admission

Put Warrant on MP Materials

CH1579878484

Admission

Put Warrant on Pfizer

CH1579877825

Admission

Put Warrant on Pfizer

CH1579877833

Admission

Put Warrant on Pfizer

CH1579877841

Admission

Put Warrant on Pfizer

CH1579877866

Admission

Put Warrant on Pfizer

CH1579877874

Admission

Put Warrant on Pfizer

CH1579877882

Admission

Put Warrant on Wheaton Precious Metals

CH1579878245

Admission

Put Warrant on Wheaton Precious Metals

CH1579878252

Admission

Put Warrant on Wheaton Precious Metals

CH1579878260

Other

Strike/Barrier Adjustments SG - 09.07.2026

The following strike/barrier adjustments were made:

Admission

10.36% p.a. Barrier Reverse Convertible on Newmont

CH1555861520

Admission

10.60% p.a. Barrier Reverse Convertible on Take 2 Interactive

CH1555861496

Admission

12.16% p.a. Barrier Reverse Convertible on Freeport-McMoRan

CH1555861512

Admission

14.78% p.a. Barrier Reverse Convertible on Take 2 Interactive

CH1555861504

Admission

15.51% p.a. Barrier Reverse Convertible on SpaceX

CH1555861447

Admission

27.72% p.a. Barrier Reverse Convertible on Micron Technology

CH1555861454

Admission

9.46% p.a. Barrier Reverse Convertible on Eli Lilly

CH1555861421

Delisting

Leonteq Securities AG - Early Redemptions

CH1447740304, CH1292093346

Reason for the redemption: Issuer Call Last Trading Date: 8 July 2026 Publication as of: 8 July 2026

Delisting

Leonteq Securities AG - Early Redemptions

CH1484608513

Reason for the redemption: Issuer Call Last Trading Date: 8 July 2026 Publication as of: 8 July 2026

Delisting

Leonteq Securities AG - Early Redemptions

Diverse gemäss Anhang

The instruments in the attached annex are subject to an early redemption. Reason for the redemption: Delisting Last Trading Date: 8 July 2026 Publication as of: 7 July 2026

Listing

Leonteq Securities AG - Zulassung zum Handel (Sponsored Segment)

US81517B1017

Beschrieb: Zulassung zum Handel. Kontakt: David Haab, Leonteq Securities AG, Europaallee 39, 8004 Zürich Telefon: +41 58 800 10 43 E-Mail: david.haab@leonteq.com Erster Handelstag: 08.07.2026 Datum der Veröffentlichung: 07.07.2026 Für die folgenden Instrumente wird die Zulassung zum Handel beantragt (Sponsored Share): US81517B1017

Delisting

Short Mini Future auf BB Biotech AG

CH1173490538

Delisting

Short Mini Future auf Siemens AG

CH1520609509